Clinical trials
Phase 2 Obesity trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 16 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Active, not recruiting | 9 |
| Recruiting | 8 |
| Not yet recruiting | 7 |
| Unknown status | 5 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Minwei Biotechnology Co., Ltd | 5 |
| Beijing QL Biopharmaceutical Co.,Ltd | 3 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Boehringer Ingelheim | 2 |
| BrightGene Bio-Medical Technology Co., Ltd. | 2 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2 |
| Hudson Biotech | 2 |
| Shandong Suncadia Medicine Co., Ltd. | 2 |
| The United Bio-Technology (Hengqin) Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 50 |
| Overweight | 33 |
| Diabetes Mellitus, Type 2 | 3 |
| Weight Loss | 2 |
| Body Weight | 1 |
| Diabetes Mellitus | 1 |
| Endometrial Hyperplasia | 1 |
| Endometrial Neoplasms | 1 |
| Insulin Resistance | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.